Endo (ENDP) Slides as CEO 'Transition Plan' Includes CEO Retiring...and Nothing Else
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Needham & Company Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Underperform
December 14, 2012 8:56 AM ESTNeedham & Company downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Hold to Underperform.
The firm comments, "We are lowering our rating on shares of Endo Health Solutions to Underperform from Hold. While shares current oversold condition (in our view) and existence of likely... More
Endo Health (ENDP) in Search of CEO
December 12, 2012 5:27 PM ESTEndo Health Solutions Inc. (Nasdaq: ENDP) announced today David P. Holveck, 67, President and Chief Executive Officer, will retire in 2013. He will continue to serve in his present positions until the earlier of his successor being in place or the May 2013 annual meeting of Endo... More
